Paul Phelps, MD
Ophthalmic Plastic and Reconstructive Surgery · Chicago, ILNPI 1003131657
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $113,969 of the $140,915 with a category attached, or 80.9%. Amgen accounts for 93.0% of it on its own, with 15 other manufacturers making up the rest.
Across 242 payments — averaging $582.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$131K
- Lumenis BE Inc$6K
- Oyster Point Pharma, Inc.$2K
- Alcon$485
- Glaukos Corporation$410
- AbbVie$348
- plus $875 from 10 others
Across 2 payments — averaging $18,304 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$37K
What the payments were for
- Consulting fees$5,2004%
- Speaking & faculty fees$113,96981%
- Travel & lodging$7,7065%
- Food & beverage$14,04110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 207 | $131,046 |
| Lumenis BE Inc | 1 | $5,932 |
| Oyster Point Pharma, Inc. | 2 | $1,819 |
| Alcon | 5 | $485 |
| Glaukos Corporation | 5 | $410 |
| AbbVie(2 entities) | 5 | $348 |
| Biotissue Holdings Inc. | 2 | $249 |
| Galderma Laboratories, L.p. | 2 | $170 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $113 |
| Tarsus Pharmaceuticals, Inc. | 5 | $110 |
| Henry Schein, Inc. | 1 | $78 |
| Revance Therapeutics, Inc. | 1 | $50 |
| Aerie Pharmaceuticals, Inc. | 2 | $36 |
| Lumibird Medical Inc. | 1 | $33 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$123,150
- M22$5,932
- RESTASIS$148
- Clareon$148
- BOTOX$147
- Hydrus Microstent$145
- ENVISTA$113
- iStent Trabecular Micro-Bypass System Model iS3$108
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TepezzaTeprotumumab-Trbw | 13 | $815,522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenTepezza | $131,046 | $815,52213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few ophthalmic plastic and reconstructive surgery providers in Illinoison file to place this against a meaningful peer group, so we don't.
Other ophthalmic plastic and reconstructive surgery in Chicago
- Kenya WilliamsChicago$23K
- Liza CohenChicago$5K
- Hassan ShahChicago$1K
- Olivia ChengChicago$1K
- Sasha HubschmanChicago$406
- Tamara FountainDeerfield$1M
- Krishna PatelWheaton$4K
- Stephen WinklerDes Plaines$3K
- Jamie KeenHines$1K
- Duaa SharfiMerrionette Park$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.